Walkey Carl
Insider CIK 1843189 · NLTX Senior Vice President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-08-02 | 2022-08-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-02-01 | 2022-02-02 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-08-03 | 2021-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-06-16 | 2021-06-17 | 600 | $10.19 | $6.1K | 1,352,489 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-06-09 | 2021-06-11 | 650 | $10.82 | $7.0K | 1,353,089 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-06-08 | 2021-06-09 | 600 | $11.00 | $6.6K | 1,353,739 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-06-04 | 2021-06-07 | 600 | $10.00 | $6.0K | 1,354,339 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-05-26 | 2021-05-26 | 600 | $10.00 | $6.0K | 1,354,939 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-05-19 | 2021-05-21 | 600 | $10.63 | $6.4K | 1,355,539 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-05-12 | 2021-05-12 | 1,200 | $11.09 | $13.3K | 1,354,762 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-05-05 | 2021-05-06 | 1,200 | $11.30 | $13.6K | 1,355,962 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-04-28 | 2021-04-30 | 2,400 | $12.58 | $30.2K | 1,357,162 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-04-26 | 2021-04-27 | 600 | $13.00 | $7.8K | 1,359,562 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-04-21 | 2021-04-22 | 1,800 | $11.98 | $21.6K | 1,360,162 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-04-14 | 2021-04-16 | 1,800 | $12.22 | $22.0K | 1,361,962 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-04-07 | 2021-04-08 | 1,800 | $12.02 | $21.6K | 1,363,762 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-04-05 | 2021-04-06 | 600 | $13.00 | $7.8K | 1,365,562 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-31 | 2021-04-02 | 1,800 | $11.96 | $21.5K | 1,366,162 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-24 | 2021-03-24 | 1,800 | $11.95 | $21.5K | 1,367,962 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-22 | 2021-03-24 | 600 | $12.00 | $7.2K | 1,369,762 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-17 | 2021-03-18 | 1,200 | $11.36 | $13.6K | 1,370,362 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-10 | 2021-03-11 | 1,800 | $11.97 | $21.5K | 1,371,562 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-03 | 2021-03-04 | 1,800 | $11.87 | $21.4K | 1,373,362 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-02-25 | 2021-02-25 | 600 | $13.00 | $7.8K | 1,375,162 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-02-24 | 2021-02-25 | 1,800 | $12.14 | $21.9K | 1,375,762 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-02-17 | 2021-02-18 | 2,400 | $12.70 | $30.5K | 1,377,562 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-02-10 | 2021-02-12 | 3,000 | $14.20 | $42.6K | 1,379,962 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-02-05 | 2021-02-09 | 600 | $14.00 | $8.4K | 1,382,962 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-02-03 | 2021-02-05 | 2,400 | $13.23 | $31.8K | 1,383,562 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-01-30 | 2021-02-02 | 45,000 | — | $0 | 45,000 | SEC↗ |